OncoVanta Therapeutics
PrivateCompany Overview
OncoVanta Therapeutics operates in Healthcare & Life Sciences and is based in Hagerstown, Maryland.
OncoVanta Therapeutics is a biotechnology company that develops TCR-T Cell therapies targeting mutant TP53-driven solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoVanta Therapeutics Comparables
Compare OncoVanta Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anocca | 83% | |
| Affini-T Therapeutics | 82% | |
| 3T Biosciences | 79% |
For institutional investors. Book with your work email.
OncoVanta Therapeutics Funding Rounds
Historical fundraising activity
OncoVanta Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OncoVanta Therapeutics's valuation, stock price, and market status.
Is OncoVanta Therapeutics a public or private company?
OncoVanta Therapeutics is a private company.
What is the current stock price of OncoVanta Therapeutics?
OncoVanta Therapeutics is a private company, so its shares have no public market price. Caplight tracks OncoVanta Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OncoVanta Therapeutics worth (valuation)?
Valuation information for OncoVanta Therapeutics is not publicly available.
Can I buy OncoVanta Therapeutics stock?
OncoVanta Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OncoVanta Therapeutics's last funding round?
Funding round information for OncoVanta Therapeutics is not publicly available.
Who are the main investors in OncoVanta Therapeutics?
Investor information for OncoVanta Therapeutics is not publicly disclosed.
Will OncoVanta Therapeutics IPO soon?
No public IPO plans have been announced for OncoVanta Therapeutics.
How can I track OncoVanta Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in OncoVanta Therapeutics's shares on secondary markets.